2

2555
353-211 General Principles
for Medical Science III

4(4-0-8)
353-212 General Principles

for Medical Science IV

4(3-3-7)
1

353-221 Skin and related

connective tissue infection

4(3-3-7)
353-231 Hematopoietic and

Lymphoreticular System

4(3-3-7)
411-324 English for

Medical Science I

3(3-0-

6)

Module : 353-211 General Principles for Medical Science III

: ..

: . .

4(4-0-8)

: Tel

sura_wng@kku.ac.th

sorujsr@kku.ac.th

043-363808, 043-348385

50

88

Conference

SG

11
3

Attending SG 4.5%, MEQ

6.5%

5
6

PDM

0.5

0.5

Module

100

353-212 General Principles for Medical Science IV

: ..
: . .

4(3-3-7)

wiprua@kku.ac.th

boonmars@yahoo.com

 : Tel. 043-363434, 04336-3268

1
2

3
4
5

11

,PDM 2
Conference lab
ANS drug
SG

PDM

()

34 ( 170)

62

33 (65)

24

3 (5)

6 (30)

11

1 = 5
1 = 5
Conference lab lab
ANS drug 1 lab 5

SG 4.4%, MEQ 6.6%

Universal precaution, Gram stain ,

0.5 (2.5)

0.5

Stool Exam (lab +)

0.5 (2.5)

0.5
5

275

100

353-211 General Principles for Medical Science III : Week 1

21
..
55

08.00
09.00
SDL

09.00

10.00 - 11.00

-10.00
353 211: L1
Introduction to
Immunology
Preclinical
Medicine 2

11.00
-12.00

353 211:
L2
Production
and
function of
granulocyte
s, NK, mac

13.00 - 14.00

14.00 -

15.00

16.00-

353 211: L3
Production
and function
of T
lymphocytes

15.00
353 211: L4
.Production
and function
of B
lymphocytes

-16.00
SDL

17.00
SDL

353 211:
L5
Nature of
Ig

22 .

55

353 211:
L6
Antigen,
Antigenicity
and
immunogeni
city

24 .
55

3501 3506

353 211:L10-11:
Immunologic mediators

23 .
55

SDL

411 324 :

353 211: L12

Immunogenetics

353
211:L13
Immune
2 response

2 mechanisms

(1)

353 211:L15-16
Microcirculation &
Edema

353 211:
25 . L19 Acute
55
Inflammatio
n ()

SDL

411 324 :

3501 3506

353 211:
353 211: L21
L20 Chronic Reparative
inflammatio processes
n

353
211:L22

Outcome of
inflammatio
n

353 211: L7
Innate
immunity

353 211: L8-9

Immunological principles
underlying diagnostic
laboratory tests

353 211: L14.

Immune
response
mechanisms
(2)

SDL

SDL

353 211:L17-18.Acute
Inflammation, including cells
and mediators

SDL

SDL

SDL

SDL

353 211:L23
353 211:
Introduction to L24
pharmacology Pharmacokine
tics I
2

08.00
09.00 -10.00
09.00
L353
353 211: L26
211:L25
Pharmacokinetic
Inflammatory
s II
28 . responses

55

29 .
55

353-211 General Principles for Medical Science III: Week 2

353 211:
L30
Physiology
of ANS

353 211: L31

Sympathomimeti
c and
sympatholytic
drugs1

10.00 - 11.00

11.00 -12.00

353 211:
L27
Pharmacokine
tics III

353 211 L28

Pharmacodyna
mics I

SDL

411 324 :

3501 3506

353 211: L32-33

30 . Sympathomimetic and
55
sympatholytic drugs 2,3

353 21:L34
Parasympatho
mimetic
drugs

353 21:L35
Parasympatholy
tic
drugs

13.00 14.00
353 211 L29
Pharmacodyna
micsII

14.00 15.00

15.00
-16.00

SDL

16.0017.00

SDL

353 212 : Lab1: Infammation and

repair (Sec 02)
Lab. 8
353 212: Lab2. : Pharmacokinetic
(Sec 01)

PBL

Lab.1-2

2 Bio-Ethic

and
Laws (
)

SDL

SDL

353 211:L36-37
Neoplasia

2
31 .

55
353 211:L38-39

SDL

411 324 :

3501 3506

353 211: L40 353 211: L41

Principles of
Immunizations
Cell and Molecular Biology of specimen
Neoplastic Development
collections for
1
2 pathology

..55

2
2

10

PDM

. .
353 211:
353 211:

L42

General
Immunology
properties
SDL
(Summary)
of autacoids

SDL

08.00

09.00

10.00 -

11.00

09.00

-10.00

11.00

-12.00

..55

353-211 General Principles for Medical Science III: Week 3

353 211:L44-45:
Hypersensitivities

411 324 :

..55

13.00 -

14.00 -

15.00

16.00-

14.00

15.00

-16.00

17.00

353 212 .Lab1: Inflammation and

repair (Sec 01)

SDL

SDL

3501 3506

SDL

Lab. 8
353 212 Lab 2: Pharmacokinetic (Sec
02)

..55

Gen.3: Case 1 :
SG 1

353 211:L46-47: Cancer

SDL

chemotherapy

11

SDL

Lab.3-4

Bio-Ethic and Laws

( Orthopedics)

.., .

SDL

..55

411 324 :

RE

SDL

353 212 Lab 3: Neoplasia (Sec 01)

Lab. 8

353 212 :Lab 4:Immunology (Sec.02)

3501 3506

Lab.7

353 212 :Lab3: Neoplasia (Sec 02)

Gen.3: Case 1 :
SG 2

..55

Lab. 8

RE

353 212 Lab4: Immunology (Sec 01)

SDL

SDL
SDL

Lab.7

353-211 General Principles for Medical Science III : Week 4

08.00
09.00

09.00 -10.00

10.00-

11.00-

11.00

12.00

12

13.00-14.00

14.00

15.00-

16.00-

-15.00

16.00

17.00

11

..55

RE

Gen.3: Case 1 : SG 3

Case

353 211: L48:

Alterations in
immunologic
function

353

353 212:

Transplant

Lab2.

211 :L49:
rejection

Conf.

Pharmacoki

netic

SDL

353

12

..55

211:L50:

:L51:

Pharmacog
enetics

Immunomodu

lating agents

13

..55

SDL

SDL (sec.02)

353 211

411 324 :

3501 3506

SDL

353 212: Case study Drugs Affecting on

ANS (sec.01)

4202 -

4405

SDL

353 212 : Case study Drugs Affecting on

ANS (sec.02)

350413

353 212: Conf.

Case study
Drugs Affecting
on ANS

CPC

SDL

3507,3509-3512,3514,

3516--3522 5

SDL (sec.01)

14

411 324 :

SDL

..55

SDL

SDL

3501 3506

15
..55

SDL

SDL

SDL

353-211 General Principles for Medical Science III 353-212 General Principles for Medical
Science IV :

08.00-

18

09.00

SD
L

09.00-10.00

Exam

10.0011.00

11.00-12.00

Week 5

13.0014.00

14.00-

15.00-

15.00

16.00

SDL

MCQ 1 : Gen 3

.. 55
14

16.00-17.00


19

.. 55

Exam

SD
L

20

411 324 :

Course

orientation

353 212:
353 212:
L1
:Morphology of L2:
bacteria &
Bacterial
nutrition
requirement
genetics

.. 55 2

3501 3506

MCQ 2 : Gen 3

353 212:
L3:

Specimen
collection
for

2 2 microbiolog

Exam

Gen 3

353 212:

MEQ:

SDL

Pitfall in Neurosurgery

SDL

PCT Neuro

21
.. 55

22

.. 55

353 212: L 4-5: Host

Exam Lab
SDL

parasite relationship

Patho

Lab 8
15

()

SDL

SDL

353-212 General Principles for Medical Science IV : Week 6

/

25

..

08.00-09.00

09.00-10.00

10.00-11.00

353 212: L6-7:

353 212: L8:

antimicrobial

(3); Macrolides,

Classification of

..
55

linicosamides,

chloramphenicols
2

26

12.00

Antimicrobial

lactam antibiotics (1-2)

55

11.00-

353 212:
L9:

Introduction

to Mycology

353

212:L10:
Diseases

caused by

SDL

13.00-14.00

14.00-15.00

L353 212: 11-12 :

Antimicrobial (4-5);
Aminoglycosides, tetracyclines,
sulfonamides, Metronidazole,
fluoroquinolones

15.0016.00

16.0017.00

SDL

411 324 :

353 212:L13:

353 212:

Systemic and

L14:

fungal infection

drugs

3501 3506

opportunistic

fungal

infections
16

Antifungal

SDL

353 212:

27

..
55

L15 :

Introduction to

28

..
55

353 212:

353 212:

Viral

Viral- host

to virology

replication

Introduction

parasitology

L19

353 212: L18:

protozoa

Medical

353 212: L16-17 :Medical

SDL

()

353 212: Lab 5:; Sterile technique, dilution

L20 :

relationship

& precaution (Sec 01)

Lab 7/,

411 324 :
SDL

353 212: Lab 6: Demons Protozoa (Sec

3501 3506

SDL

02)
Lab 5-6/

29

353 212: L21-22: Anti

viral

353 212: L23

Medical

Trematodes

353 212:
L24

353 212: Lab 5: Sterile technique, dilution &

precaution (Sec 02) ;

Medical

Lab7/ ,

17

SDL

..

55

Trematodes
2

353 212: Lab 6 :Demons Protozoa (Sec 01)

;

Lab 5-6/

353-212 General Principles for Medical Science IV: Week 7

/

08.00-09.00

09.00-10.00

10.00-11.00

11.00-12.00

353 212: L25-26

Case 2: SG1

..

55

14.0015.00

15.00-16.00 16.00-17.00

Grams stain (Sec 01)

Acanthocephalans

13.00-14.00

353 212: Lab7: Collection of specimen &

Medical Cestodes and

Lab7/ ,
353 212: Lab8 : Demons. Trematodes and

SDL

Cestodes-Acanthro, (Sec02)

Lab 5-6 /
353 212:
3

..

L27:

Microbial

353 212:
L28:

Antiseptic &

RE

411 324 :

3501 3506

353 212: Lab7: Collection of specimen &

Grams stain (Sec 02)

Lab7/ ,
18

RE

growth
55

Disinfectant

control

..
55

..
55

353 212: L30:

Medical

Medical

nematodes

55

353 212:
L31

Antiparasitic
drugs

RE

Case 2: SG 3

RE

nematodes

Medical

353 212: Lab9 : Fungi & Virus

(Sec.01):

Lab 7/
(Sec 02)

RE:
case
()

19

RE

Lab 5-6 /

353 212: Lab 9 : Fungi &

SDL

353 212: Lab 10 : Demons Nematodes

3501 3506

353 212: L31:

Arthropods

411 324 :

Lab 5-6 /
353 212:

Case2: SG2

..

Cestodes-Acanthro, (Sec01)

L29

353 212: Lab8 : Demons. Trematodes and

Virus(Sec.02):

Lab 7/
353 212: Lab 10 : Demons Nematodes

SDL

(Sec 01)

Lab 5-6/

353-212 General Principles for Medical Science IV : Week 8

/

08.00-

09.00-10.00

09.00

10.0011.00

11.00-

12.00

14.00-

13.00-14.00

15.00

15.0016.00

PDM: Practice Stool exam (Sec 0

9 ..

1);

sterile technique

SDL

LAB 7

55

(Sec 02)

10

353 212:

353 212:

411 324 :

L33:

L34:

Pathophysiol Epidemiolog

ogy

y Prevention

.. 55 and

Diagnosis of
Parasitic

Infections

Control

3501 3506

Practice Grams
stain (Sec 02);

Lab 5-6/

()

16.00-19.00

PDM: Practice

SDL

Stool exam (Sec 0

2);

Lab 7/

Practice
Grams stain
(Sec0 1);

Lab 5-6/ Lab 7/

(Sec 01)

SDL

20

11

.. 55

12

MEQ
SDL

08.30-9.30

411 324 :

MCQ: ( L1 14)

3501 3506

Bacteria , Fungus,

SDL

.. 55

13

.. 55

13.00 -15.00

antibacterial + antifungal

SDL

drugs,
13.00-15.00

MCQ (L16-34) 8.30.0011.00

SDL

Virus, Parasites, antiviral,

antiparasite +

(spot)- stool

SDL

exam /

()

stain)

21

(Grams

Lab 5-6, 7

SDL

353-212 General Principles for Medical Science IV : Week 9

/

08.00-

09.00

09.00-10.00

10.00-

11.00-

13.00-

14.00-

15.00-

16.00-

11.00

12.00

14.00

15.00

16.00

17.00

16

.. 55

17

1
411 324 :

SDL

.. 55

3501 3506

18

Atopic dermatitis in

SDL

Children

.. 55

19

SDL

.
SDL

411 324 :

3501 3506

.. 55

22

SDL


20

SDL

SDL

.. 55

Module : 353 221

Skin and related connective tissue 4(3-3-7)

: ..
: ..

wilmot@kku.ac.th

parpra@kku.ac.th

: Tel. 043-363173, 043-363671

/
23

29

60

18

25

Conference

14

PDM

0.5

SG

MEQ = 8%

0.5

100

353 221 Skin and related connective tissue:

24

= 6%

Week 10


23

..55

24

08.00-09.00
Orientation

25

12.00

L2-3:Organ structure
L1:
Embryology of and function
skin

Tissue infection

SDL

411 324 :

3501 3506

L9-10: Bacterial skin and soft

L11-12 : Viral skin

Tissue infection

infection

..55

L14
Parasitic skin

26

11.00

L7-8 : Bacterial skin and soft

..55

09.00-10.00

11.00-

infection

L15
Parasitic skin
infection

L4 : Repair,

regeneration of
the skin

()

411 324 :
3501
- 3506
25

14.00-

15.00-

15.00

16.00

16.0017.00

L5-6 : Body Temp.

and control

SDL

Lab1: Dissection of skin & cutaneous nerve. (Sec

01):
Lab gross /
PDM : (Sec 02)

(Advance and Team work skill)

L13 : Fungal
skin infection

SDL

13.00-14.00

10.00-

SDL

Lab 2: Microbiology I (Sec 01):

Lab.7/ ,

Lab1: Dissection of skin & cutaneous

nerve(Sec 02):

SDL
SDL

..55

27

..55

L16: Parasitic
Skin infection

Lab 3: Histology and embryology of the

skin (Sec 01)

Lab. 8/ ,
2

Lab gross /

Lab 2: Microbiology I (Sec 02)

Lab.7/ ,
PDM : (Sec 01)

(Advance and Team

(Sec 02) SDL

work skill)

26

SDL

SDL

30
..55

08.0009.00

09.0010.00

10.0011.00

353 221 Skin and related connective tissue: Week 11

11.00-12.00

L17-18:

CASE 1: SG 1

Dermal inflammation

13.00-14.00

14.0015.00

Lab 4: Parasite(Sec 01)

15.0016.00

Lab. 5-6/
Lab 3: Histology and embryology of
the skin (Sec 02)

16.0017.00

SDL

Lab. 8/ ,

RE

31
2
..55

1
..55

L19-20 Dermal

RE

CASE 1: SG 2

SDL

inflammation

411 324 :

3501 - 3506

SDL

RE: Case summary

SDL

27

SDL

..55

3
..55

28

353 221 Skin and related connective tissue:

08.0009.00

L 21

..55

09.0010.00

L22

Trauma

Tumor

and skin

disorder

injury

10.0011.00

L23
Insect bite

..55

..55

13.00-14.00

L24

L25

Antifungal

Antihistamin

& antiviral

agents

Tumor disorder

2 SDL

CASE 2: SG 1

3501 - 3506

L28
L29
Topical
Corticostero
drugs for
common
id
bacterial
and
parasitic

skin disease

29

16.00

16.0017.00

SDL

411 324 :

15.00

15.00-

L26-27

14.00-

11.00-12.00

Week 12

Lab5: Pathology (Sec 01)

Lab. 8/

SDL

Lab 4: Parasite (Sec 02)

Lab. 8/
SDL

SDL
RE

RE

..55

Lab 6: Micro II (Sec 02)

411 324 :

3501 - 3506

Lab.7/ ,

SDL

(Sec 01):SDL
Lab5: Pathology(Sec 02)

10

..55

CASE 2: SG 2

RE : Case summary

Lab. 8/

Lab 6: Micro II (Sec 01)

SDL

Lab.7/,

353 221 Skin and related connective tissue:

Week 13

08.00-

09.00-

10.00-

11.00-

13.00-

14.00-

15.00-

16.00-

09.00

10.00

11.00

12.00

14.00

15.00

16.00

17.00

30


13

..54

411 324 :

14

SDL

..54

SDL

3501 -

3506

15

..54

SDL

MCQ

411 324 :

16

17

SDL

..54

SDL

3501 -

MEQ

Lab (sec 01,02)

Lab. 7

3506

SDL

SDL

SDL

..54

31

SDL

SDL

Module : 353 231 Hematopoietic and Lymphoreticular System

: ..

: ...

: Tel

4(3-3-7)

tipeka@kku.ac.th

chapie@kku.ac.th

043-363808, 043-348385

69.65

35

35

27

Lecture for Lab

17.91

MCQ
MCQ:
5

Spot test
1, 3, 4, 6, 7, 9

32

Practice
3
4

11.94

SG 4.78 %, MEQ 7.16

% (40:60)

0.5

100

353 231 Hematopoietic and Lymphoreticular System : Week 14

/

8.00-9.00

9.00-10.00

10.00-11.00

11.00-12.00 12-13 13.00-14.00

33

14.00-15.00

15.00-

16.00-

16.00

17.00

Orientation

20

..55

21

..55

22

..55

and

lymphoid
2

L6: RBC 3 :

hemoglobi
n

L1: Blood

SDL

organs 1

L2: Blood and

L3: Blood

L4: RBC 1 :

organs2

organs 3

and metabolism and its

lymphoid

and lymphoid

Delvelopment

L5: RBC 2 :
Hemoglobin

composition
2

Systemic
infection

SDL

411 324 :

SDL

L7 :

SDL

L8-10: Hemostasis

3501 3506

SDL

L11: SIRS,

L12:Cytomegalo L13:
virus, Epstein-

Dengue and

L14:

Syndrome

Barr virus and

Chikunguny

Disease of the

Sepsis

HTLV-I
a
2

2
2

34

Hemolytic
Newborn

SDL

L15: Red cell

L16: AIDS

disorder1

23 .

55

SDL

411 324 :

L17-18:

3501 3506

SDL

SDL

SDL

SDL

24

L19: (For LAB

L20: Red cell

2) LAB 1 Blood and lymphoid organ (SEC0 1)

disorder2

LAB 8/

..55 WBC

L21:

disease

and diagnosis

LAB 2:
WBC (SEC 02)

2 LAB 7/

353 231 Hematopoietic and Lymphoreticular System

/

08.00-9.00
L22:

27

09.00-10.00

10.00-11.00

LAB 2 : Complete Blood Count

11.00-

12.00-

12.00

13.00

(SEC 01)

Morphology of

LAB 5, 6/
red cell disorder LAB 1 Blood and lymphoid organ (SEC 02)

35

13.00-14.00

: Week 15
14.0015.00

15.00-16.00

L23-24: White cell

L25:

disorder

Hemostasis

disorder

16.0017.00
SDL

..55

L26:

28

..55

LAB 8/

L27: (For

Hemostasis

LAB 3,7)

disorder

LAB 3 ABO Blood grouping and

Antiglobulin test (SEC 01)

SDL

411 324 :

3501 3506

LAB 5-6/ .
SDL
SDL

(SEC 02)

..55

L28:Symptoms

and signs in
30

..55

CASE 1: SG 1

29

Hematopoietic
and

RE

411 324 :

3501 3506

LAB 3: ABO Blood grouping and
Antiglobulin test (SEC 02)
LAB 7./
SDL (SEC 01)

Lymphoreticula
r System

2
36

SDL
SDL

31

L29: (For
LAB5)
Screening tests
for bleeding
disorder

..55

L30:Trypan
osomiasis,
Leishmanias
is,
Babesiosis,
Filaria, and
Schstosomia
sis

LAB 5 Screening tests for bleeding disorder

(SEC 01)
LAB 3- 4/
LAB 4
RBC,
WBC (Sec 02)

..55

8.00-9.00

9.00-10.00

L32:

LAB 4
RBC,
WBC
(SEC 01)
LAB
8/ , .

SDL

SDL

353 231 Hematopoietic and Lymphoreticular System

10.00-11.00

LAB 8/ ,

L31: Malaria

11.00-12.00

LAB 5 Screening tests for bleeding disorder

. (SEC 02)
LAB 5- 6 /
37

12.0013.00

: Week 16

13.00-14.00

14.0015.00

15.0016.00

16.0017.00

LAB 6 Malaria, filariasis and

hemoflagellates. (SEC 01)
LAB 5- 6/
SDL (SEC 02)

SDL

CASE 1: SG

411 324 :

SDL

3501 3506

..55

..55

L33: Blood
Components
Therapy

RE

L34:

LAB 1-2/
LAB 6 Malaria, filariasis and
hemoflagellates. (SEC 02)
L35:

Transfusion

Reaction

L36:
Chemothera
py and
6
immunosupp
..55 ressive
drugs

LAB 7:
(SEC 01)

LAB 5-6/

Bio-Ethic and Laws

L37:
Anticoagul

anti

platelet

411 324 :

3501 3506

CASE 1: SG 3

RE

2
38

SDL

L38:

ant and

SDL

SDL

SDL

LAB 7:
. (SEC 02)
LAB 3-4/

SDL

..55

(SEC 01) SDL

353 231 Hematopoietic and Lymphoreticular System

/

8.00-9.00

9.00-10.00

10.00-11.00

11.00-12.00 12-13

15.00

15.00-16.00

16.0017.00

( SEC 01)

10

SDL

..55

LAB 5- 6/

SDL

LAB 9:

( SEC 02)
LAB 8/

..55

14.00

14.00-

LAB 8:

11

13.00-

: Week 17

411 324 :
SDL

SDL

3501 3506

LAB 9:
(SEC 01)
LAB 8/
LAB 8:

SDL

( SEC 02)
LAB 5- 6/

12

SDL

SDL

..55

CPC

39

SDL


13

411 324 :

SDL

..55

3501 3506
10.30-

14

..55

SDL

MEQ

(SEC 01)
SPOT TEST

11.30

SDL

Blood
examination

SDL

LAB 7

(SEC 02) CBC

LAB 5, 6

for malaria

LAB 5, 6

15 -30

MCQ

2555
2555

40

SDL
(SEC 02)
SPOT TEST

LAB 7

(SEC 01) CBC

LAB 5, 6